This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Estee Lauder (EL) Q3 Earnings & Sales Beat, Outlook Raised
by Zacks Equity Research
Estee Lauder's (EL) top and bottom lines improve year over year and surpass estimates in Q3. The company continues to gain from strength in most categories.
Estee Lauder (EL) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 19.23% and 4.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Beats on Q1 Earnings & Revenues, Q2 View Soft
by Zacks Equity Research
The performance can be attributed to Nu Skin's (NUS) technology and business expansion initiatives as well as customer acquisition and retention program.
This Week's Must-See Earnings Charts
by Tracey Ryniec
Which stocks will traders be watching this busy earnings week? These are some of those at the top of the list.
What's in Store for Rent-A-Center (RCII) in Q1 Earnings?
by Zacks Equity Research
Rent-A-Center (RCII) is benefitting from growth in Acceptance Now and Core U.S. segments which are likely to aid Q1 results. Also, the company is on track with cost-saving initiatives.
Central Garden & Pet (CENT) Q2 Earnings: What's in Store?
by Zacks Equity Research
Central Garden & Pet (CENT) may face tough year-over-year comparison in organic sales. Bell Nursery has traditionally exhibited profit in the company's third quarter.
The Zacks Analyst Blog Highlights: Cigna, Ceridian, Estee Lauder, Arconic and Fortinet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cigna, Ceridian, Estee Lauder, Arconic and Fortinet
Monster Beverage (MNST) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Monster Beverage's (MNST) robust trends in the energy drinks category might boost sales and earnings in first-quarter 2019. However, concerns regarding higher input and freight costs remain.
Why Earnings Season Could Be Great for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's What You Should Note Ahead of Funko (FNKO) Q1 Earnings
by Zacks Equity Research
Funko (FNKO) is likely to benefit from strong domestic and international demand in Q1. However, costs related to fulfilling the rising demand may pressurize margins.
Will Lower Core Sales Hurt Newell's (NWL) Earnings in Q1?
by Zacks Equity Research
Newell (NWL) witnesses decline in core sales, which might hurt overall sales in first-quarter 2019.
Can AB InBev (BUD) Return to Earnings Beat Trend Amid Woes?
by Zacks Equity Research
AB InBev's (BUD) first-quarter 2019 earnings may continue to struggle due to soft trend of beer sales in the United States. However, its premiumization efforts and global brands' strength bode well.
Estee Lauder (EL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Disappointment in Store for B&G Foods (BGS) in Q1 Earnings?
by Zacks Equity Research
B&G Foods' (BGS) margins are under pressure due to increased freight costs. Also, Pirate Brands' divestiture is likely to weigh on sales in Q1, though buyouts should offer some cushion to the stock.
Factors to Watch Ahead of Hanesbrands' (HBI) Q1 Earnings
by Zacks Equity Research
Hanesbrands (HBI) is likely to witness organic sales growth in Q1. However, raw-material inflation is a threat.
5 Top Stocks to Buy Ahead of Earnings This Week
by Nalak Das
Last week, the market benchmark S&P 500 Index and tech-heavy Nasdaq Composite recorded new all-time highs.
Helen of Troy (HELE) Q4 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Helen of Troy's (HELE) Q4 performance benefits from improved margins as well as strength in the Housewares businesses. However, sluggish Health & Home unit disappoints.
Colgate (CL) Q1 Earnings & Sales Top Estimates, Stock Up
by Zacks Equity Research
Colgate (CL) delivers top and bottom-line beat in first-quarter 2019, benefiting from favorable pricing and volume growth. However, adverse currency remains a hurdle.
Molson Coors (TAP) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Molson Coors (TAP) to gain from improved pricing, International strength and cost savings in first-quarter 2019. Soft North America volume, input cost inflation and currency headwinds may persist.
Here is Why Growth Investors Should Buy Estee Lauder (EL) Now
by Zacks Equity Research
Estee Lauder (EL) possesses solid growth attributes, which could help it handily outperform the market.
Service Corporation Q1 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Service Corporation (SCI) Q1 results gained from strong performance in the cemetery category. However, lower funeral revenues impacted the company's performance.
Organic Sales to Drive Church & Dwight (CHD) in Q1 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2019 results are set to gain on organic sales growth. Also, acquisitions are likely to serve as tailwinds, while high costs are a concern.
Factors Likely to Decide Avon's (AVP) Fate in Q1 Earnings
by Zacks Equity Research
Soft Representatives growth and currency headwind are likely to mar Avon's (AVP) Q1 results. However, the Open Up Avon strategy may bring some respite.
Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on its 2020 Strategy, focus on e-commerce growth and brand-management initiatives.
Estee Lauder (EL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.